| Dr Katie Ann Mcpherson, MD | |
|
3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 | |
| (615) 322-3000 | |
| Not Available |
| Full Name | Dr Katie Ann Mcpherson |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 11 Years |
| Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114365624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0058871 (Colorado) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 61032 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vanderbilt University Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
North Carolina State University engineers have demonstrated a flexible device that harvests the heat energy from the human body to monitor health. The device surpasses all other flexible harvesters that use body heat as the sole energy source.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
Modular Genetics, Inc. is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly. Modular's lead product is a "green" surfactant initially targeting the personal care market.
› Verified 4 days ago
| Entity Name | Vanderbilt University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
North Carolina State University engineers have demonstrated a flexible device that harvests the heat energy from the human body to monitor health. The device surpasses all other flexible harvesters that use body heat as the sole energy source.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
Modular Genetics, Inc. is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly. Modular's lead product is a "green" surfactant initially targeting the personal care market.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katie Ann Mcpherson, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: (615) 936-2000 | Dr Katie Ann Mcpherson, MD 3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 Ph: (615) 322-3000 |
News Archive
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
North Carolina State University engineers have demonstrated a flexible device that harvests the heat energy from the human body to monitor health. The device surpasses all other flexible harvesters that use body heat as the sole energy source.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
Modular Genetics, Inc. is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly. Modular's lead product is a "green" surfactant initially targeting the personal care market.
› Verified 4 days ago
Megan Desai, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Spurthi N Bhatt, MD MPH Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 | |
Aladraine Sands, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 275 Cumberland Bnd, Nashville, TN 37228 Phone: -- |